Establishment of gene diagnosis and therapy for Endometrial carcinoma.
子宫内膜癌基因诊断和治疗的建立。
基本信息
- 批准号:07457391
- 负责人:
- 金额:$ 4.67万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. We made various fragments derived from a human chromosome 1 by high dose radiation, and transferred them into endometrial carcinoma cells via microcell fusion. The introduction of a whole chromosome 1 resulted in the morphological alteration followed by cell senescence. In addition, telomerase activity was also suppressed in the microcell hybrids containing a chromosome 1. Evaluation of cell morphology in addition to telomerase activity in the microcell hybrid clones containing various fragments form chromosome 1 disclosed that 1q11-q21 or q31-ter region of chromosome 1 was critical for the suppression of endometrial cell growth properties.2. We established the reconstituted cells expressing that mutant K-Ras protein constitutively. Enchanced expression of ER protein that has a function as a transcription factor was shown in this cell. We also established the reconstituted cells expressing both the wild type of K-Ras protein and ER protein. Long term culture in the presence of 10% calf serum transformed the cell that was analogous to the level in the mutant K-Ras expressing cells, was shown in this transformed cells. These implicate ER protein in Ras-mediated transformation.
1. 我们通过高剂量辐射制造了源自人类1号染色体的各种片段,并通过微细胞融合将它们转移到子宫内膜癌细胞中。整个 1 号染色体的引入导致形态改变,随后细胞衰老。此外,含有1号染色体的微细胞杂交体中端粒酶活性也受到抑制。对含有1号染色体各种片段的微细胞杂交体克隆中的细胞形态和端粒酶活性进行评估发现,1号染色体的1q11-q21或q31-ter区域对于抑制子宫内膜细胞生长特性至关重要。 2.我们建立了组成型表达突变 K-Ras 蛋白的重组细胞。该细胞中显示出具有转录因子功能的 ER 蛋白表达增强。我们还建立了表达野生型 K-Ras 蛋白和 ER 蛋白的重组细胞。在存在10%小牛血清的情况下长期培养转化的细胞与突变型K-Ras表达细胞中的水平类似,在该转化的细胞中显示。这些表明 ER 蛋白参与 Ras 介导的转化。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Arima,T.,: "Malignant trophoblastic neoplasms with different modes of origin." Cancer Genet Cytogenet. 88. 5-15 (1995)
Arima,T.,:“具有不同起源模式的恶性滋养细胞肿瘤。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kato K: "The level of ER protein expression is increased in NIH3T3 cell transformed by oncogenic K-Ras 4B : Sex Steroid Hormone Action In in vitro culture syste." Churchill Living stone Japan. 31-40 (1996)
Kato K:“致癌 K-Ras 4B 转化的 NIH3T3 细胞中 ER 蛋白表达水平增加:体外培养系统中性类固醇激素的作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kato,K.,: "Endometriosis today" Analysis of danazol action.(in press),
Kato,K.,:“今天的子宫内膜异位症”达那唑作用分析。(正在印刷中),
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kato K: "Sex Steroid Hormone Action In in vitro culture system." The level of ER protein expression is increased in NIH3T3 cell transformed by oncogenic K-Ras 4B, 31-40 (1996)
Kato K:“性类固醇激素在体外培养系统中的作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Koto, K.,: "The level of ER protein expression is increased in NIH3T3 cell transformed by oncogenic K-Ras 4B: Sex Steroid HOrmone Action In in vitro culture system." Churchill Living stone (Japan). (in press).
Koto, K.,:“在体外培养系统中,通过致癌 K-Ras 4B 转化的 NIH3T3 细胞中 ER 蛋白表达水平有所增加:性类固醇激素作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAKE Norio其他文献
Transcriptional factors, DEC1 and DEC2 cooperatively regulate epithelial-to-mesenchymal transition of uterine endometrial cancer cells.
转录因子DEC1和DEC2协同调节子宫内膜癌细胞的上皮间质转化。
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
ASANOMA Kazuo;KOBAYASHI Hiroaki;WAKE Norio;KATO Kiyoko - 通讯作者:
KATO Kiyoko
WAKE Norio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAKE Norio', 18)}}的其他基金
Genome diversity associated with in montalization and establishment of endometrial cancer stem cell isolation
与子宫内膜癌干细胞分离的蒙塔化和建立相关的基因组多样性
- 批准号:
20390435 - 财政年份:2008
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular targeted therapy by inducing cancer cell senesence
通过诱导癌细胞衰老的分子靶向治疗
- 批准号:
14104014 - 财政年份:2002
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Molecular mechanism of endometrial carcinoma development and their application for the new molecular target therapy
子宫内膜癌发生的分子机制及其在新型分子靶向治疗中的应用
- 批准号:
12470344 - 财政年份:2000
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism of cell senescence
细胞衰老的分子机制
- 批准号:
11557121 - 财政年份:1999
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism of endometrial cancer and its application to gene diagnosis
子宫内膜癌的分子机制及其在基因诊断中的应用
- 批准号:
09470362 - 财政年份:1997
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new therapy for uterine cervical carcinoma
宫颈癌新疗法的开发
- 批准号:
08557092 - 财政年份:1996
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Genetic Events Associated With Choriocarcinogenesis.
与绒毛膜癌发生相关的遗传事件。
- 批准号:
07042006 - 财政年份:1995
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for international Scientific Research
Development of gene diagnosis and therapy for endometrial cancers.
子宫内膜癌基因诊断和治疗的发展。
- 批准号:
05454453 - 财政年份:1993
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Application of antisense oligo DNA to uterine cancers.
反义寡DNA在子宫癌中的应用。
- 批准号:
05557073 - 财政年份:1993
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Genetic events associated with human endometrial carcinogenesis.
与人类子宫内膜癌发生相关的遗传事件。
- 批准号:
03454399 - 财政年份:1991
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
網羅的なCpG siteのDNAメチル化の検索による肺腺癌のtumor suppressor geneの同定
综合寻找CpG位点DNA甲基化鉴定肺腺癌抑癌基因
- 批准号:
23K08296 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Modeling Breast Cancer Associated with KMT2C as a Haploinsufficient and Recessive Tumor Suppressor Gene
与作为单倍体不足和隐性肿瘤抑制基因 KMT2C 相关的乳腺癌建模
- 批准号:
491638 - 财政年份:2023
- 资助金额:
$ 4.67万 - 项目类别:
Miscellaneous Programs
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis
正常和恶性造血过程中增强 RNA 介导的肿瘤抑制基因表达
- 批准号:
10755937 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
Comprehensive modeling of tumor suppressor gene-derived neoantigens in pancreatic cancer
胰腺癌中抑癌基因衍生的新抗原的综合建模
- 批准号:
10389366 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
SNF2 Histone Linker PHD RING Helicase as a novel tumor suppressor gene and risk factor in lung adenocarcinoma development
SNF2 组蛋白连接器 PHD RING 解旋酶作为新型抑癌基因和肺腺癌发展的危险因素
- 批准号:
472467 - 财政年份:2022
- 资助金额:
$ 4.67万 - 项目类别:
Operating Grants
Investigation of therapeutic targets in KRAS-mutant lung cancer cells co-existing multiple tumor suppressor gene mutations
共存多种抑癌基因突变的 KRAS 突变肺癌细胞治疗靶点的研究
- 批准号:
21K20793 - 财政年份:2021
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Mechanism of neuroendocrine tumor suppression by the tumor suppressor gene PHLDA3
抑癌基因PHLDA3抑制神经内分泌肿瘤的机制
- 批准号:
20H03523 - 财政年份:2020
- 资助金额:
$ 4.67万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The Single Cell Biology of Context-Specific Responses to Loss of the RB Tumor Suppressor Gene
对 RB 肿瘤抑制基因丢失的特定反应的单细胞生物学
- 批准号:
419746 - 财政年份:2020
- 资助金额:
$ 4.67万 - 项目类别:
Operating Grants
3'UTR-dependent regulation of the PTEN tumor suppressor gene
PTEN 肿瘤抑制基因的 3UTR 依赖性调节
- 批准号:
10212969 - 财政年份:2020
- 资助金额:
$ 4.67万 - 项目类别:
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
研究 Max 作为小细胞肺癌和其他神经内分泌肿瘤的抑癌基因
- 批准号:
10662195 - 财政年份:2020
- 资助金额:
$ 4.67万 - 项目类别: